McKesson stock gained 1.46 percent after CVS pact extension
Published on 10/06/2026 at 14:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson stock (ISIN US58155Q1031) closed at USD 915.45 on the NYSE on October 5, 2026, up 1.46 percent from USD 902.28. The company extended its pharmaceutical distribution partnership with CVS Health through June 2032 and reaffirmed its fiscal 2027 adjusted EPS guidance.
CVS agreement extends through 2032
According to McKesson on October 1, 2026, the agreement in principle covers CVS mail-order and specialty pharmacies, retail pharmacies, and distribution centers through June 2032. The companies have worked together for more than 25 years.
The agreement is not yet a final contract. McKesson said negotiations could be delayed or fail to produce a definitive extension, making execution the key counter-factor behind the otherwise longer revenue visibility.
Guidance stays above USD 44
McKesson reaffirmed fiscal 2027 adjusted EPS guidance of USD 44.20-45.00 and a long-term adjusted EPS growth target of 13%-16%, according to McKesson. The next update is scheduled for the fiscal second-quarter earnings call on November 4, 2026.
The latest reported quarter also set a measurable base. McKesson posted USD 105.38 billion in revenue and adjusted EPS of USD 9.93, compared with USD 103.88 billion and USD 9.56 expected by analysts, according to MarketBeat. Revenue increased 7.7 percent year over year, while adjusted EPS exceeded consensus by USD 0.37.
Consensus target stands above the close
MarketBeat reports a Moderate Buy consensus based on 14 Buy ratings and four Hold ratings, with an average price target of USD 973.44. That target lies 6.3 percent above the October 5 closing price, while Royal Bank of Canada maintained a Sector Perform rating and an USD 845 target on September 14, 2026, according to MarketBeat.
McKesson stock holds above USD 900
McKesson stock closed at USD 915.45 on October 5, 2026, with a 52-week range of USD 723.68 to USD 999.00 and market capitalization of USD 107.2 billion. The price was 8.4 percent below the 52-week high, leaving the CVS renewal, earnings execution, and contract completion as the central variables for the next report.
McKesson stock facts
- Company: McKesson Corporation
- ISIN: US58155Q1031
- Ticker: MCK
- Trading venue: NYSE
- Price (as of October 5, 2026, 4:00 p.m. ET): USD 915.45 Closing price (October 5, 2026)
- Market capitalization: USD 107.2 billion (as of October 5, 2026)
- 52-week range: USD 723.68-999.00 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Distribution
Upcoming dates for McKesson stock
- November 4, 2026: Fiscal second-quarter earnings call
